Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Ioflupane binds to dopamine transporters on presynaptic dopaminergic nerve terminals in the striatum. After labelling with iodine-123, its regional distribution is visualised using SPECT; reduced striatal uptake indicates loss of functional dopaminergic terminals.
Indications / reported uses
Diagnostic SPECT imaging in adults with clinically uncertain parkinsonian syndromes to help differentiate essential tremor from presynaptic parkinsonian syndromes
Adjunctive imaging to help differentiate probable dementia with Lewy bodies from Alzheimer’s disease; the scan does not distinguish Parkinson’s disease from multiple system atrophy or progressive supranuclear palsy
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Ioflupane PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ioflupane Permitted Daily Exposure (PDE) report (the Ioflupane PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ioflupane Occupational Exposure Limit (OEL) report (the Ioflupane OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.